Spero Therapeutics (2HA) Q2 2024 Earnings Report
DE:2HA Q2 2024 EPS Results
- Actual EPS
- -EUR 0.30
- Consensus EPS
- -EUR 0.34
- Beat/Miss
- Beat by +EUR 0.04
- One Year Ago EPS
- -EUR 0.21
DE:2HA Q2 2024 Revenue Results
- Actual Revenue
- EUR 5.39M
- Expected Revenue
- EUR 4.39M
- Beat/Miss
- Beat by +EUR 1.00M
- YoY Revenue Growth
- +663.58%
Earnings Announcement Details
- Quarter
- Q2 2024
- Date
- 08/05/2024
- Time
- After Close
- Conference Call
- Monday, August 5, 2024
DE:2HA Upcoming Earnings
Spero Therapeutics's next earnings date is estimated for November 16, 2026, based on past reporting schedules.
Q2 2024 Earnings Call Audio
DE:2HA Q2 2024 Earnings Call
0:00 / 0:00
Q2 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:2HA Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 16, 2026 | 2026 (Q3) | -0.42- | -0.12 | ― | ― |
| Aug 12, 2026 | 2026 (Q2) | ―-0.14 | -0.03 | -433.33% (-0.12) | |
| May 13, 2026 | 2026 (Q1) | ―-0.12 | -0.22 | 48.00% (+0.11) | |
| Mar 26, 2026 | 2025 (Q4) | -0.180.47 | -0.34 | 239.47% (+0.81) | |
| Nov 13, 2025 | 2025 (Q3) | -0.22-0.12 | -0.29 | 59.38% (+0.17) | |
| Aug 12, 2025 | 2025 (Q2) | -0.34-0.03 | -0.3 | 90.91% (+0.27) | |
| May 13, 2025 | 2025 (Q1) | -0.49-0.22 | -0.21 | -4.17% (-0.01) | |
| Mar 27, 2025 | 2024 (Q4) | -0.28-0.34 | 0.86 | -139.58% (-1.20) | |
| Nov 14, 2024 | 2024 (Q3) | -0.24-0.29 | -0.05 | -433.33% (-0.23) | |
| Aug 05, 2024 | 2024 (Q2) | -0.34-0.30 | -0.21 | -43.48% (-0.09) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
